Lucid Diagnostics Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Lucid Diagnostics Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2020 to Q4 2023.
  • Lucid Diagnostics Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $42.2M, a 62.2% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $42.2M +$16.2M +62.2% Dec 31, 2023 10-K 2024-03-25
Q4 2022 $26M +$11.5M +79.3% Dec 31, 2022 10-K 2024-03-25
Q4 2021 $14.5M +$9.7M +202% Dec 31, 2021 10-K 2023-03-14
Q4 2020 $4.8M Dec 31, 2020 10-K 2022-04-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.